About MedWorks

This author has not yet filled in any details.
So far MedWorks has created 121 blog entries.

A Scholarly Sting Operation Shines a Light on ‘Predatory’ Journals

By |2021-11-11T17:14:06-08:00March 23rd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The New York Times today reported that researchers writing for the journal, Nature, found that There are now thousands of fake open-access journals, about as many as legitimate ones. The authors created a fake 'Editor" that they then applied to numerous 'scientific journals.' The applicant’s nom de plume was not [...]

Taking a Chapter from Depression Treatment, Parkinson’s Therapy Gets Fresh Look From Device Makers

By |2021-11-11T17:15:08-08:00January 9th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Deep brain stimulation, an established therapy that modifies the brain's circuitry to treat symptoms of depression, Parkinson's disease and other movement disorders, is attracting fresh attention from medical-device makers who believe it is underused. St. Jude Medical Inc. recently introduced a new DBS system in the U.S., and Boston Scientific [...]

A Psychiatrist’s Quest to Understand PTSD: MDMA in the MIX

By |2021-11-11T17:15:19-08:00January 7th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Charles Marmar, a 71-year-old psychiatrist in New York, has spent his career studying post traumatic stress disorder, which has symptoms such as sleep disruption and vivid flashbacks of the traumatic experience. PTSD is often associated with war: Between 11% and 20% of veterans who served in Iraq and Afghanistan have [...]

Albuminuria Linked to Increased Risk for Dementia, Cognitive Impairment

By |2021-11-11T17:15:31-08:00December 21st, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Although past research has shown a link between renal dysfunction and cognitive impairment, a new systematic review shows that the presence of albuminuria specifically is also associated with an increased risk of developing cognitive impairment. The meta-analysis of 22 studies, each with at least 100 participants, was carried out to [...]

FDA to Pull Black-Box Warning on Chantix for Psychotic Side Effects

By |2021-11-11T17:15:39-08:00December 20th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Seven years after safety concerns altered the trajectory of Pfizer’s stop-smoking med Chantix, the FDA has pulled its black-box warning from the drug’s label, according to a well known online pharmaceutical news site, FiercePharma. FDA officials removed the warning after weighing data from the EAGLES postmarketing study showing that Chantix [...]

Marijuana Use Trends: In Pregnancy and Among Adult General Population

By |2021-11-11T17:15:47-08:00December 20th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014 Qiana L. Brown, Aaron L. Sarvet, Dvora Shmulewitz Methods The Columbia University Medical Center institutional review board waived review of this study. Informed oral consent was obtained from each participant. Data from women aged 18 through 44 years from the annual National Survey on [...]

Personality Traits Tied to Genome Areas & Mental Illness

By |2021-11-11T17:15:56-08:00December 20th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Researchers have identified six regions of the human genome that are significantly linked to personality traits, and some show significant correlations to certain psychiatric disorders as well. The study, conducted by researchers at the University of California San Diego School of Medicine, is based on a meta-analysis of genome-wide association [...]

Shortcuts to Addiction

By |2021-11-11T17:16:05-08:00December 8th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Psychiatrist Anna Lembke, chief of addiction medicine at Stanford University’s medical school, has spent her career helping patients battle their addiction to opioid drugs, from Vicodin to heroin. Out of this experience comes “Drug Dealer, MD,” a short and feisty book in which, among much else, she calls out practitioners [...]

Vagus Nerve Stimulation: Handheld Device in the Works to Heal the Body

By |2021-11-11T17:16:12-08:00December 6th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Every breath we take, especially the slow, deep breathing used in meditation, stimulates the vagus nerve to calm the body. Scientists also believe stimulating the nerve with small electrical impulses can have far reaching potential to treat medical conditions including migraines, rheumatoid arthritis and strokes. Targeting nerves for treatment is [...]

Arthritis Drug Can Boost Antidepressant Effect

By |2016-11-13T17:51:47-08:00November 13th, 2016|We Know Psychiatry|

Giving severely depressed patients the arthritis drug celecoxib (brand name Celebrex) dramatically boosted the effectiveness of their antidepressant medication, according to new research. Patients were randomly assigned to receive the antidepressant escitalopram (Lexapro) plus celecoxib or Lexapro plus a placebo. The study found that 78 percent of the patients in the [...]

Title

Go to Top